UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 29, 2023
Accession Number:
0001193125-23-175035
Submission Type:
POS AM
CIK:
0000891293
Company Name:
CTI BIOPHARMA CORP
File Number:
333-266926